title: Development of acute gouty attack in the morbidly obese population after bariatric surgery.
abstract: BACKGROUND
  Gout is associated with increased body weight. We evaluated the prevalence of gout and acute gouty attacks in the morbidly obese population who underwent bariatric surgery.
  
  
  METHODS
  The medical records and operative reports of 1,240 patients who underwent bariatric surgery were reviewed retrospectively for weight parameters, BMI, weight loss, medical history of gout, and onset of acute gouty attacks.
  
  
  RESULTS
  Of the 1,240 patients, 5 (0.4%) had been previously diagnosed with gout. 2 of these 5 had acute attacks during the postoperative period, and responded successfully to intravenous colchicine.
  
  
  CONCLUSIONS
  Although rare, gout must be considered a co-morbid illness in obese and morbidly obese patients. Surgeons should be familiar with the signs and symptoms of attacks in the postoperative period, and be knowledgeable in the management.
authors.affiliation: Bariatric Institute, Section of Minimally Invasive Surgery, Cleveland Clinic Florida, Weston, FL 33331, USA.
authors.forename: Priscila
authors.initials: P
authors.lastname: Antozzi
authors.forename: Flavia
authors.initials: F
authors.lastname: Soto
authors.forename: Fernando
authors.initials: F
authors.lastname: Arias
authors.forename: Lester
authors.initials: L
authors.lastname: Carrodeguas
authors.forename: Trumane
authors.initials: T
authors.lastname: Ropos
authors.forename: Natan
authors.initials: N
authors.lastname: Zundel
authors.forename: Samuel
authors.initials: S
authors.lastname: Szomstein
authors.forename: Raul
authors.initials: R
authors.lastname: Rosenthal
mesh_terms: D000208:Acute Disease; D000328:Adult; D000368:Aged; D049088:Bariatrics; D015992:Body Mass Index; D001835:Body Weight; D003078:Colchicine / Q000008:administration & dosage / Q000627:therapeutic use; D006073:Gout / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D006074:Gout Suppressants / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D012189:Retrospective Studies; D013997:Time Factors; D015431:Weight Loss
chemical_list: D006074:Gout Suppressants; D003078:Colchicine